import { useState } from 'react';
import { Card, CardHeader, CardTitle, CardDescription, CardContent } from '@/components/ui/card';
import { Badge } from '@/components/ui/badge';
import { Heart, Wind, Droplets, Activity, Brain, ChevronDown, ChevronUp } from 'lucide-react';

interface OrganModule {
  id: string;
  title: string;
  icon: any;
  color: string;
  topics: string[];
  clinicalPearls: string[];
  detailedContent: {
    pathophysiology: {
      title: string;
      content: string[];
    }[];
    mechanisms: {
      title: string;
      description: string;
      steps: string[];
    }[];
    clinicalScenario: {
      presentation: string;
      labs: string[];
      management: string[];
    };
    keyEquations?: string[];
  };
}

const modules: OrganModule[] = [
  {
    id: 'lungs',
    title: 'Respiratory System',
    icon: Wind,
    color: 'text-blue-500',
    topics: [
      'ARDS pathophysiology',
      'V/Q mismatch mechanisms',
      'Hypoxemia vs hypercapnia',
      'Pulmonary capillary leak',
      'Ventilation strategies'
    ],
    clinicalPearls: [
      'PaOâ‚‚/FiOâ‚‚ < 300 defines ARDS',
      'Shunt fraction increases with alveolar flooding',
      'PEEP recruits collapsed alveoli'
    ],
    detailedContent: {
      pathophysiology: [
        {
          title: 'ARDS: Three Phases of Lung Injury',
          content: [
            '**Exudative Phase (Days 0-7):** Diffuse alveolar damage, neutrophil infiltration, hyaline membrane formation. Cytokines (IL-1, IL-6, TNF-Î±) drive endothelial and epithelial injury.',
            '**Proliferative Phase (Days 7-21):** Type II pneumocyte proliferation attempts to restore alveolar architecture. Fibroblast activation begins.',
            '**Fibrotic Phase (>21 days):** Collagen deposition, permanent scarring. Decreased compliance, increased dead space.'
          ]
        },
        {
          title: 'V/Q Mismatch: The Core Problem',
          content: [
            'Normal V/Q ratio = 0.8 (ventilation slightly less than perfusion at lung bases)',
            '**Shunt (V/Q = 0):** Perfusion without ventilation. Classic in ARDS with alveolar flooding. Unresponsive to supplemental Oâ‚‚.',
            '**Dead Space (V/Q = âˆž):** Ventilation without perfusion. Seen in PE, emphysema. Results in hypercapnia.',
            '**Low V/Q:** Atelectasis, pneumonia. Partially responsive to supplemental Oâ‚‚.'
          ]
        }
      ],
      mechanisms: [
        {
          title: 'Alveolar-Capillary Barrier Breakdown',
          description: 'How sepsis destroys gas exchange',
          steps: [
            '1. Endotoxin/cytokines activate endothelium â†’ expression of adhesion molecules (ICAM-1, VCAM-1)',
            '2. Neutrophil recruitment â†’ release of elastase, reactive oxygen species (ROS)',
            '3. Disruption of tight junctions (claudins, occludins) â†’ increased permeability',
            '4. Protein-rich fluid floods alveoli â†’ surfactant inactivation',
            '5. Alveolar collapse â†’ shunt physiology â†’ refractory hypoxemia'
          ]
        },
        {
          title: 'Hypoxic Pulmonary Vasoconstriction (HPV)',
          description: 'Compensatory mechanism that can backfire',
          steps: [
            '1. Alveolar hypoxia (PaOâ‚‚ < 60 mmHg) sensed by pulmonary artery smooth muscle',
            '2. Calcium channels open â†’ vasoconstriction of poorly ventilated regions',
            '3. Blood diverted to well-ventilated alveoli (improves V/Q matching)',
            '4. BUT: Global hypoxia â†’ global vasoconstriction â†’ pulmonary hypertension',
            '5. Right ventricular strain â†’ cor pulmonale in severe ARDS'
          ]
        }
      ],
      clinicalScenario: {
        presentation: 'A 52-year-old with pneumonia develops worsening dyspnea despite 6L NC Oâ‚‚. Bilateral infiltrates on CXR. PaOâ‚‚/FiOâ‚‚ = 180. Mechanically ventilated with ARDSNet protocol.',
        labs: [
          'ABG: pH 7.32, PaCOâ‚‚ 48, PaOâ‚‚ 65 (on FiOâ‚‚ 60%)',
          'PaOâ‚‚/FiOâ‚‚ ratio: 108 (severe ARDS)',
          'Lung compliance: 22 mL/cmHâ‚‚O (normal: 50-100)',
          'Static plateau pressure: 32 cmHâ‚‚O (target â‰¤30)'
        ],
        management: [
          '**ARDSNet ventilation:** Tidal volume 6 mL/kg IBW, Pplat â‰¤30 cmHâ‚‚O',
          '**PEEP titration:** Start 10-15 cmHâ‚‚O, adjust to optimize oxygenation/compliance',
          '**Permissive hypercapnia:** Accept pH â‰¥7.20 to avoid barotrauma',
          '**Prone positioning:** If PaOâ‚‚/FiOâ‚‚ <150, prone 16 hrs/day (improves mortality)',
          '**Conservative fluid management:** Target CVP 4-6, avoid fluid overload (worsens pulmonary edema)'
        ]
      },
      keyEquations: [
        'PaOâ‚‚/FiOâ‚‚ ratio = PaOâ‚‚ Ã· (FiOâ‚‚/100) â€” ARDS severity: Mild <300, Moderate <200, Severe <100',
        'Alveolar gas equation: PAOâ‚‚ = (FiOâ‚‚ Ã— [Patm - PHâ‚‚O]) - (PaCOâ‚‚/0.8)',
        'A-a gradient = PAOâ‚‚ - PaOâ‚‚ â€” Normal <15, â†‘â†‘ in V/Q mismatch',
        'Shunt fraction (Qs/Qt) = (CcOâ‚‚ - CaOâ‚‚) / (CcOâ‚‚ - CvOâ‚‚) â€” Normal <5%, ARDS can be >30%'
      ]
    }
  },
  {
    id: 'heart',
    title: 'Cardiovascular System',
    icon: Heart,
    color: 'text-red-500',
    topics: [
      'Septic cardiomyopathy',
      'Shock pathophysiology',
      'Cardiac output determinants',
      'Myocardial oxygen supply/demand',
      'Vasopressor mechanisms'
    ],
    clinicalPearls: [
      'Cardiac index < 2.2 indicates shock',
      'MAP goal â‰¥ 65 mmHg for perfusion',
      'Early goal-directed therapy improves outcomes'
    ],
    detailedContent: {
      pathophysiology: [
        {
          title: 'Septic Cardiomyopathy: Myocardial Depression in Sepsis',
          content: [
            '**Incidence:** 40-50% of septic patients develop reversible LV/RV dysfunction',
            '**Mechanism:** Cytokines (TNF-Î±, IL-1Î²) â†’ myocardial depressant substances â†’ â†“ contractility despite normal/elevated cardiac output',
            '**Paradox:** EF may drop to 30-40%, but CO maintained via extreme vasodilation (â†“â†“ SVR) and tachycardia',
            '**Recovery:** Usually resolves in 7-10 days if patient survives sepsis'
          ]
        },
        {
          title: 'Determinants of Cardiac Output',
          content: [
            '**CO = Stroke Volume (SV) Ã— Heart Rate (HR)**',
            '**SV determined by:** Preload (LVEDV), Afterload (SVR), Contractility (inotropy)',
            '**Frank-Starling:** â†‘ Preload â†’ â†‘ SV (up to a point â€” then overload)',
            '**Afterload sensitivity:** â†‘ SVR â†’ â†“ SV (critical in heart failure, compensated in healthy hearts)',
            '**HR optimization:** Too slow â†’ low CO. Too fast â†’ inadequate diastolic filling â†’ low CO'
          ]
        }
      ],
      mechanisms: [
        {
          title: 'Cardiogenic Shock Cascade',
          description: 'Forward and backward failure propagation',
          steps: [
            '1. Myocardial insult (MI, myocarditis) â†’ â†“ contractility â†’ â†“ stroke volume',
            '2. â†“ Cardiac output â†’ â†“ coronary perfusion â†’ worsening ischemia (vicious cycle)',
            '3. â†‘ LVEDP â†’ pulmonary edema â†’ hypoxemia â†’ further myocardial injury',
            '4. Compensatory mechanisms fail: SNS overdrive â†’ arrhythmias, RAAS â†’ fluid retention',
            '5. â†“ Renal perfusion â†’ prerenal AKI (cardiorenal syndrome)',
            '6. â†“ Hepatic perfusion â†’ "shock liver" (â†‘â†‘ transaminases, â†‘ bilirubin)'
          ]
        },
        {
          title: 'Septic Shock: Distributive Vasodilation',
          description: 'Opposite pathophysiology to cardiogenic shock',
          steps: [
            '1. Endotoxin â†’ massive cytokine release â†’ inducible nitric oxide synthase (iNOS)',
            '2. NO production â†’ profound vasodilation â†’ â†“â†“ SVR (often <600 dynesÂ·s/cmâµ)',
            '3. "Warm shock:" â†‘ Cardiac output (compensatory), warm extremities, bounding pulses',
            '4. Microcirculatory dysfunction: Shunting, endothelial injury â†’ tissue hypoperfusion despite â†‘ CO',
            '5. Late: Septic cardiomyopathy â†’ â†“ CO â†’ "cold shock" (poor prognosis)',
            '6. End result: â†“ Oxygen delivery (DOâ‚‚) â†’ â†‘ lactate â†’ multi-organ failure'
          ]
        }
      ],
      clinicalScenario: {
        presentation: 'A 68-year-old presents with chest pain, anterior STEMI. Post-cath: LAD stented, but EF 25%. Hypotensive (BP 78/52) despite IVF. Cool extremities, altered mental status.',
        labs: [
          'Cardiac index: 1.6 L/min/mÂ² (normal: 2.5-4.0) â€” cardiogenic shock',
          'CVP: 18 mmHg (elevated â€” backward failure)',
          'Lactate: 6.2 mmol/L (tissue hypoperfusion)',
          'Troponin: 45 ng/mL (massive MI)',
          'BNP: 1200 pg/mL (volume overload)'
        ],
        management: [
          '**Inotropic support:** Dobutamine 5-10 mcg/kg/min (â†‘ contractility, â†“ afterload)',
          '**If still hypotensive:** Add norepinephrine (cautious â€” â†‘ afterload can worsen CO)',
          '**Mechanical support:** Consider IABP (â†‘ coronary perfusion, â†“ afterload) or Impella',
          '**Diuresis:** Gentle with furosemide to â†“ pulmonary edema (avoid aggressive â€” worsens preload)',
          '**AVOID:** Large volume resuscitation (worsens pulmonary edema)'
        ]
      },
      keyEquations: [
        'Cardiac Output (CO) = Stroke Volume Ã— Heart Rate',
        'Cardiac Index (CI) = CO / BSA (normal: 2.5-4.0 L/min/mÂ²)',
        'Mean Arterial Pressure (MAP) = CO Ã— SVR (simplified: DBP + 1/3 pulse pressure)',
        'Systemic Vascular Resistance (SVR) = 80 Ã— (MAP - CVP) / CO (normal: 800-1200 dynesÂ·s/cmâµ)',
        'Oxygen delivery (DOâ‚‚) = CO Ã— CaOâ‚‚ Ã— 10 (normal: 900-1100 mL/min)'
      ]
    }
  },
  {
    id: 'kidneys',
    title: 'Renal System',
    icon: Droplets,
    color: 'text-cyan-500',
    topics: [
      'AKI staging (KDIGO)',
      'Prerenal vs intrinsic vs postrenal',
      'ATN mechanisms',
      'Fluid responsiveness',
      'Renal recovery patterns'
    ],
    clinicalPearls: [
      'Oliguria < 0.5 mL/kg/hr for 6+ hours',
      'Creatinine rise lags behind injury',
      'FENa < 1% suggests prerenal AKI'
    ],
    detailedContent: {
      pathophysiology: [
        {
          title: 'AKI Pathophysiology: Prerenal â†’ Intrinsic Transition',
          content: [
            '**Prerenal (70% of AKI):** â†“ Renal perfusion (hypovolemia, hypotension, CHF). Kidneys structurally intact. Reversible if perfusion restored.',
            '**Intrinsic (25%):** Direct tubular/glomerular injury. Most common: Acute tubular necrosis (ATN) from prolonged ischemia or nephrotoxins.',
            '**Postrenal (5%):** Obstruction (BPH, stones, tumor). Bilateral obstruction or single kidney required for AKI.',
            '**Critical transition:** Prerenal AKI â†’ if untreated >24 hrs â†’ ATN (tubular cell death, sloughing into lumen)'
          ]
        },
        {
          title: 'KDIGO Staging: Severity Classification',
          content: [
            '**Stage 1:** Creatinine 1.5-1.9Ã— baseline OR â‰¥0.3 mg/dL increase OR urine <0.5 mL/kg/hr Ã— 6-12 hrs',
            '**Stage 2:** Creatinine 2.0-2.9Ã— baseline OR urine <0.5 mL/kg/hr Ã— â‰¥12 hrs',
            '**Stage 3:** Creatinine â‰¥3.0Ã— baseline OR â‰¥4.0 mg/dL OR urine <0.3 mL/kg/hr Ã— â‰¥24 hrs OR anuria Ã— 12 hrs',
            '**Stage 3 also:** Initiation of RRT or eGFR <35 in patients <18 years'
          ]
        }
      ],
      mechanisms: [
        {
          title: 'Acute Tubular Necrosis (ATN): Cellular Level',
          description: 'How ischemia destroys tubular cells',
          steps: [
            '1. â†“ Renal blood flow â†’ preferential ischemia of S3 segment (medullary thick ascending limb)',
            '2. ATP depletion â†’ Naâº/Kâº-ATPase failure â†’ cell swelling, loss of polarity',
            '3. Actin cytoskeleton disruption â†’ brush border loss â†’ tubular cells slough into lumen',
            '4. Tubular obstruction (cellular debris casts) â†’ â†‘ intratubular pressure â†’ â†“ GFR',
            '5. Backleak of filtrate through damaged epithelium â†’ further â†“ GFR',
            '6. Recovery: Surviving cells proliferate, tubule regenerates over 7-21 days'
          ]
        },
        {
          title: 'Cardiorenal Syndrome Type 1',
          description: 'How acute heart failure causes AKI',
          steps: [
            '1. â†“ Cardiac output â†’ â†“ renal perfusion pressure â†’ prerenal azotemia',
            '2. Renal hypoperfusion â†’ RAAS activation â†’ angiotensin II â†’ efferent arteriole constriction',
            '3. Initially maintains GFR (â†‘ glomerular pressure), but worsens medullary ischemia',
            '4. Venous congestion: â†‘ CVP â†’ â†‘ renal venous pressure â†’ â†“ renal perfusion gradient',
            '5. "Backward failure:" Renal congestion may be more important than low CO',
            '6. Diuretic resistance develops â†’ worsening volume overload â†’ â†‘ intra-abdominal pressure â†’ abdominal compartment syndrome'
          ]
        }
      ],
      clinicalScenario: {
        presentation: 'A 62-year-old with septic shock, on norepinephrine. Day 2: Creatinine rises from 1.0 â†’ 3.2 mg/dL. Urine output 15 mL/hr despite IVF boluses. Muddy brown casts on UA.',
        labs: [
          'Creatinine: 3.2 mg/dL (baseline 1.0) â€” KDIGO Stage 3 AKI',
          'BUN: 64 mg/dL, BUN/Cr ratio: 20:1 (ATN pattern, vs 20+ in prerenal)',
          'Urine sodium: 58 mEq/L (high â€” intrinsic), FENa: 3.2% (>2% = ATN)',
          'Urinalysis: Muddy brown granular casts (pathognomonic for ATN)',
          'Urine output: 0.1 mL/kg/hr (anuric)'
        ],
        management: [
          '**Optimize hemodynamics:** Target MAP â‰¥65 mmHg (but avoid excessive vasopressors â€” renal vasoconstriction)',
          '**Avoid nephrotoxins:** Stop NSAIDs, aminoglycosides, vancomycin (if possible)',
          '**Renally dose medications:** Adjust for GFR (e.g., antibiotics, anticoagulants)',
          '**Monitor fluid status:** Daily weights, I/Os. Avoid overload (pulmonary edema) or depletion (worsens ATN)',
          '**RRT indications:** Severe metabolic acidosis (pH <7.1), hyperkalemia (>6.5), uremia (pericarditis, encephalopathy), volume overload refractory to diuretics',
          '**Recovery:** Expect diuretic phase (polyuria) in 7-14 days as tubules regenerate'
        ]
      },
      keyEquations: [
        'FENa (Fractional Excretion of Sodium) = (UNa Ã— PCr) / (PNa Ã— UCr) Ã— 100 â€” <1% prerenal, >2% ATN',
        'eGFR (CKD-EPI) â€” estimates baseline kidney function',
        'Creatinine clearance (Cockcroft-Gault) = (140 - age) Ã— weight / (72 Ã— Cr) Ã— 0.85 (if female)',
        'Urine output: Normal 0.5-1.5 mL/kg/hr, Oliguria <0.5 mL/kg/hr, Anuria <50 mL/day'
      ]
    }
  },
  {
    id: 'coagulation',
    title: 'Coagulation System',
    icon: Activity,
    color: 'text-green-500',
    topics: [
      'DIC pathophysiology',
      'Thrombotic microangiopathy',
      'Platelet consumption',
      'Coagulation cascade',
      'ISTH DIC scoring'
    ],
    clinicalPearls: [
      'DIC = bleeding + clotting simultaneously',
      'Low platelets + high D-dimer suggests DIC',
      'Fibrinogen drops as it\'s consumed'
    ],
    detailedContent: {
      pathophysiology: [
        {
          title: 'DIC: Disseminated Intravascular Coagulation',
          content: [
            '**Definition:** Systemic activation of coagulation â†’ widespread microvascular thrombosis â†’ consumption of platelets/factors â†’ paradoxical bleeding',
            '**Triggers:** Sepsis (most common), trauma, malignancy (especially AML, adenocarcinomas), obstetric (placental abruption, amniotic fluid embolism)',
            '**Mechanism:** Tissue factor release â†’ thrombin generation â†’ fibrin clots everywhere â†’ consumption coagulopathy',
            '**Lab hallmarks:** â†“ Platelets, â†“ fibrinogen, â†‘ PT/PTT, â†‘â†‘ D-dimer, schistocytes on smear'
          ]
        },
        {
          title: 'ISTH DIC Scoring System',
          content: [
            '**Platelet count:** >100 = 0, 50-100 = 1, <50 = 2 points',
            '**D-dimer:** No increase = 0, Moderate increase = 2, Strong increase = 3',
            '**PT prolongation:** <3 sec = 0, 3-6 sec = 1, >6 sec = 2',
            '**Fibrinogen:** >100 mg/dL = 0, <100 = 1',
            '**Score â‰¥5 = Overt DIC** (compatible with diagnosis)'
          ]
        }
      ],
      mechanisms: [
        {
          title: 'DIC Cascade: From Sepsis to Bleeding',
          description: 'How systemic inflammation destroys coagulation',
          steps: [
            '1. Endotoxin/cytokines (TNF-Î±, IL-6) â†’ tissue factor expression on endothelium/monocytes',
            '2. Tissue factor + Factor VIIa â†’ extrinsic pathway activation â†’ thrombin burst',
            '3. Widespread microthrombi in capillaries (brain, kidneys, lungs, skin)',
            '4. Consumption: Platelets and clotting factors (V, VIII, fibrinogen) depleted',
            '5. Fibrinolysis activation (plasmin) â†’ breakdown of clots â†’ â†‘â†‘ D-dimer, fibrin split products (FSP)',
            '6. Bleeding: Surgical sites, IV sites, mucous membranes, GI tract',
            '7. Microangiopathic hemolytic anemia (MAHA): RBCs sheared by fibrin strands â†’ schistocytes'
          ]
        },
        {
          title: 'Platelet Consumption: Thrombocytopenia in Critical Illness',
          description: 'Why platelets drop in sepsis/MODS',
          steps: [
            '1. Increased utilization: Microthrombi formation consumes platelets',
            '2. Splenic sequestration: Enlarged spleen in sepsis traps platelets',
            '3. Decreased production: Bone marrow suppression from infection/inflammation',
            '4. Antibody-mediated destruction: HIT (heparin-induced thrombocytopenia) if on heparin',
            '5. Dilutional: Massive transfusion washes out platelets',
            '6. Target: Maintain platelets >50K (bleeding), >100K (neurosurgery/active bleeding)'
          ]
        }
      ],
      clinicalScenario: {
        presentation: 'A 45-year-old with gram-negative sepsis. Day 3 ICU: Oozing from IV sites, ecchymoses. Petechiae on chest. Platelets dropped from 180K â†’ 42K. PT/PTT elevated.',
        labs: [
          'Platelets: 42,000/Î¼L (normal: 150-400K) â€” severe thrombocytopenia',
          'PT: 18.2 sec (INR 1.8), PTT: 54 sec (prolonged)',
          'Fibrinogen: 98 mg/dL (normal: 200-400) â€” consumed',
          'D-dimer: >20,000 ng/mL (markedly elevated)',
          'Peripheral smear: Schistocytes present (MAHA)',
          'ISTH DIC score: 7 (overt DIC)'
        ],
        management: [
          '**Treat underlying cause:** Aggressive sepsis management (antibiotics, source control)',
          '**Platelet transfusion:** If <20K (spontaneous bleeding risk) or <50K with active bleeding',
          '**FFP (Fresh Frozen Plasma):** If PT/PTT prolonged and bleeding (replaces clotting factors)',
          '**Cryoprecipitate:** If fibrinogen <100 mg/dL (contains fibrinogen, Factor VIII, vWF)',
          '**AVOID heparin** unless thrombosis predominates (rare DIC subtype)',
          '**Monitor:** CBC, PT/PTT, fibrinogen, D-dimer daily',
          '**Prognosis:** Mortality 30-50% in sepsis-associated DIC'
        ]
      },
      keyEquations: [
        'ISTH DIC Score = Platelet pts + D-dimer pts + PT pts + Fibrinogen pts (â‰¥5 = overt DIC)',
        '4Ts Score (HIT probability) â€” distinguish HIT from other thrombocytopenia',
        'Bleeding time: Platelet function, vWD (rarely used clinically)',
        'Fibrinogen: Normal 200-400 mg/dL, critically low <100 mg/dL'
      ]
    }
  },
  {
    id: 'brain',
    title: 'Neurologic System',
    icon: Brain,
    color: 'text-purple-500',
    topics: [
      'Septic encephalopathy',
      'Hypoxic brain injury',
      'Delirium pathophysiology',
      'Cerebral perfusion pressure',
      'Metabolic encephalopathy'
    ],
    clinicalPearls: [
      'Altered mental status is often first sign',
      'Hypoxemia causes diffuse injury',
      'Sedation can mask neurologic decline'
    ],
    detailedContent: {
      pathophysiology: [
        {
          title: 'Septic-Associated Encephalopathy (SAE)',
          content: [
            '**Incidence:** Up to 70% of septic patients develop altered mental status',
            '**Mechanism:** Multifactorial â€” cytokine-mediated blood-brain barrier (BBB) disruption, cerebral hypoperfusion, microthrombi, metabolic derangements',
            '**Presentation:** Delirium, confusion, agitation â†’ obtundation â†’ coma (severe)',
            '**No structural lesion:** CT/MRI usually normal (diagnosis of exclusion after ruling out stroke, meningitis, etc.)',
            '**Prognosis:** Reversible if sepsis treated, but associated with long-term cognitive impairment'
          ]
        },
        {
          title: 'Cerebral Perfusion Pressure (CPP) and Autoregulation',
          content: [
            '**CPP = MAP - ICP** (normal ICP: 5-15 mmHg)',
            '**Autoregulation range:** Brain maintains constant blood flow despite MAP 60-150 mmHg',
            '**In critical illness:** Autoregulation impaired â†’ brain perfusion becomes pressure-passive',
            '**Hypotension:** MAP <60 â†’ cerebral hypoperfusion â†’ ischemia',
            '**Hypertension:** MAP >150 â†’ BBB breakdown â†’ cerebral edema (posterior reversible encephalopathy syndrome, PRES)'
          ]
        }
      ],
      mechanisms: [
        {
          title: 'Hypoxic-Ischemic Brain Injury (HIBI)',
          description: 'From cardiac arrest to diffuse anoxic injury',
          steps: [
            '1. Cardiac arrest â†’ cessation of cerebral blood flow â†’ ATP depletion',
            '2. Naâº/Kâº-ATPase failure â†’ cellular depolarization, excitotoxicity (glutamate release)',
            '3. Calcium influx â†’ mitochondrial dysfunction â†’ apoptosis pathways activated',
            '4. Reperfusion (ROSC) â†’ paradoxical: ROS generation, inflammation â†’ secondary injury',
            '5. Selective neuronal vulnerability: Hippocampus (CA1), cerebellum (Purkinje cells), cortex (layers 3, 5, 6)',
            '6. Outcomes: Best assessed at 72 hrs post-arrest (pupillary response, motor exam, EEG, imaging)'
          ]
        },
        {
          title: 'ICU Delirium: Pathophysiology',
          description: 'Multifactorial neurotoxicity in critical illness',
          steps: [
            '1. Neurotransmitter imbalance: â†“ Acetylcholine (attention), â†‘ dopamine (hallucinations)',
            '2. Inflammation: Cytokines cross BBB â†’ neuroinflammation',
            '3. Sleep deprivation: ICU environment (alarms, lights) â†’ circadian disruption',
            '4. Medications: Benzodiazepines (worst offenders), opioids, anticholinergics',
            '5. Metabolic: Hypoglycemia, uremia, hepatic encephalopathy',
            '6. Hypoxia/hypercapnia: CNS depression or excitation'
          ]
        }
      ],
      clinicalScenario: {
        presentation: 'A 58-year-old post-cardiac arrest (PEA, downtime 8 minutes). ROSC achieved, cooling protocol initiated. Day 2: Remains comatose, no eye opening to pain. Pupils 4 mm, minimally reactive.',
        labs: [
          'NSE (neuron-specific enolase): 82 ng/mL (>60 suggests poor prognosis)',
          'EEG: Burst suppression pattern (concerning for severe injury)',
          'CT head: Loss of gray-white differentiation (cerebral edema)',
          'MRI (Day 5): Diffuse cortical and basal ganglia DWI hyperintensity (anoxic injury)'
        ],
        management: [
          '**Targeted Temperature Management (TTM):** 32-36Â°C Ã— 24 hrs (neuroprotection, controversial benefit)',
          '**Avoid hyperthermia:** Fever worsens neurologic outcomes (target normothermia)',
          '**Hemodynamic optimization:** MAP goal 65-80 mmHg (maintain CPP)',
          '**Avoid hypoxemia/hypercapnia:** Target PaOâ‚‚ >60 mmHg, normocapnia (PaCOâ‚‚ 35-45)',
          '**Seizure prophylaxis:** EEG monitoring, treat if seizures detected (can be subclinical)',
          '**Prognostication:** Delayed until â‰¥72 hrs post-ROSC and off sedation. Poor signs: Absent pupillary/corneal reflexes, myoclonus status, malignant EEG, high NSE',
          '**Withdraw vs continue:** Shared decision-making with family, consider multimodal prognostication'
        ]
      },
      keyEquations: [
        'CPP (Cerebral Perfusion Pressure) = MAP - ICP (target CPP >60 mmHg in TBI)',
        'GCS (Glasgow Coma Scale) = Eye (1-4) + Verbal (1-5) + Motor (1-6) â€” max 15, severe â‰¤8',
        'CAM-ICU (Confusion Assessment Method) â€” delirium screening in ICU',
        'RASS (Richmond Agitation-Sedation Scale) â€” -5 (unarousable) to +4 (combative)'
      ]
    }
  }
];

export default function OrganModules() {
  const [expandedModule, setExpandedModule] = useState<string | null>(null);

  const toggleModule = (moduleId: string) => {
    setExpandedModule(expandedModule === moduleId ? null : moduleId);
  };

  return (
    <div className="space-y-6">
      <div>
        <h1 className="text-3xl font-bold mb-2">Organ System Modules</h1>
        <p className="text-muted-foreground">
          Deep dive into individual organ systems and their failure mechanisms
        </p>
      </div>

      <Card className="bg-primary/5 border-primary/20">
        <CardContent className="pt-6">
          <p className="text-sm">
            <strong>Click on any organ system below</strong> to expand detailed pathophysiology, mechanisms,
            clinical scenarios, and key equations. Each module provides board-level depth with clinical application.
          </p>
        </CardContent>
      </Card>

      <div className="space-y-4">
        {modules.map((module) => {
          const Icon = module.icon;
          const isExpanded = expandedModule === module.id;

          return (
            <Card key={module.id} className="overflow-hidden">
              <CardHeader
                className="cursor-pointer hover:bg-secondary/50 transition-colors"
                onClick={() => toggleModule(module.id)}
              >
                <div className="flex items-start justify-between">
                  <div className="flex items-center space-x-3 flex-1">
                    <Icon className={`h-8 w-8 ${module.color}`} />
                    <div className="flex-1">
                      <div className="flex items-center justify-between">
                        <CardTitle>{module.title}</CardTitle>
                        {isExpanded ? <ChevronUp className="h-5 w-5" /> : <ChevronDown className="h-5 w-5" />}
                      </div>
                      <CardDescription>{module.topics.length} key topics Â· Click to expand</CardDescription>
                    </div>
                  </div>
                  <Badge>Essential</Badge>
                </div>
              </CardHeader>

              {isExpanded && (
                <CardContent className="space-y-6 pt-6 border-t">
                  {/* Quick Overview */}
                  <div className="grid md:grid-cols-2 gap-6">
                    <div>
                      <h4 className="font-semibold text-sm mb-3">Key Topics</h4>
                      <ul className="space-y-2">
                        {module.topics.map((topic, i) => (
                          <li key={i} className="text-sm text-muted-foreground flex items-start">
                            <span className="mr-2 text-primary">â€¢</span>
                            <span>{topic}</span>
                          </li>
                        ))}
                      </ul>
                    </div>

                    <div>
                      <h4 className="font-semibold text-sm mb-3 flex items-center">
                        <span className="mr-2">ðŸ’¡</span>
                        Clinical Pearls
                      </h4>
                      <ul className="space-y-2">
                        {module.clinicalPearls.map((pearl, i) => (
                          <li key={i} className="text-xs text-muted-foreground bg-secondary/50 p-2 rounded">
                            {pearl}
                          </li>
                        ))}
                      </ul>
                    </div>
                  </div>

                  {/* Detailed Pathophysiology */}
                  <div className="space-y-4">
                    <h3 className="text-lg font-semibold border-b pb-2">Detailed Pathophysiology</h3>
                    {module.detailedContent.pathophysiology.map((section, i) => (
                      <div key={i} className="bg-secondary/30 p-4 rounded-lg">
                        <h4 className="font-semibold mb-3">{section.title}</h4>
                        <div className="space-y-2">
                          {section.content.map((paragraph, j) => (
                            <p key={j} className="text-sm text-muted-foreground leading-relaxed">
                              {paragraph}
                            </p>
                          ))}
                        </div>
                      </div>
                    ))}
                  </div>

                  {/* Mechanisms */}
                  <div className="space-y-4">
                    <h3 className="text-lg font-semibold border-b pb-2">Cellular & Molecular Mechanisms</h3>
                    {module.detailedContent.mechanisms.map((mechanism, i) => (
                      <div key={i} className="border border-primary/20 p-4 rounded-lg">
                        <div className="mb-3">
                          <h4 className="font-semibold">{mechanism.title}</h4>
                          <p className="text-sm text-muted-foreground italic">{mechanism.description}</p>
                        </div>
                        <ol className="space-y-2">
                          {mechanism.steps.map((step, j) => (
                            <li key={j} className="text-sm text-muted-foreground pl-2">
                              {step}
                            </li>
                          ))}
                        </ol>
                      </div>
                    ))}
                  </div>

                  {/* Clinical Scenario */}
                  <div className="bg-gradient-to-r from-primary/10 to-primary/5 p-6 rounded-lg space-y-4">
                    <h3 className="text-lg font-semibold border-b border-primary/30 pb-2">
                      Clinical Scenario: Application
                    </h3>

                    <div>
                      <h4 className="font-semibold text-sm mb-2">Presentation</h4>
                      <p className="text-sm text-muted-foreground">{module.detailedContent.clinicalScenario.presentation}</p>
                    </div>

                    <div>
                      <h4 className="font-semibold text-sm mb-2">Key Labs & Findings</h4>
                      <ul className="space-y-1">
                        {module.detailedContent.clinicalScenario.labs.map((lab, i) => (
                          <li key={i} className="text-sm text-muted-foreground font-mono bg-background/50 p-2 rounded">
                            {lab}
                          </li>
                        ))}
                      </ul>
                    </div>

                    <div>
                      <h4 className="font-semibold text-sm mb-2">Evidence-Based Management</h4>
                      <ul className="space-y-2">
                        {module.detailedContent.clinicalScenario.management.map((step, i) => (
                          <li key={i} className="text-sm text-muted-foreground flex items-start">
                            <span className="mr-2 text-primary font-bold">{i + 1}.</span>
                            <span>{step}</span>
                          </li>
                        ))}
                      </ul>
                    </div>
                  </div>

                  {/* Key Equations */}
                  {module.detailedContent.keyEquations && (
                    <div className="bg-secondary/50 p-4 rounded-lg">
                      <h3 className="text-lg font-semibold mb-3">Key Equations & Formulas</h3>
                      <div className="space-y-2">
                        {module.detailedContent.keyEquations.map((equation, i) => (
                          <div key={i} className="font-mono text-sm bg-background p-3 rounded border border-border">
                            {equation}
                          </div>
                        ))}
                      </div>
                    </div>
                  )}
                </CardContent>
              )}
            </Card>
          );
        })}
      </div>

      {/* Integrated Learning */}
      <Card>
        <CardHeader>
          <CardTitle>Multi-Organ Interactions</CardTitle>
          <CardDescription>How these systems affect each other in critical illness</CardDescription>
        </CardHeader>
        <CardContent>
          <div className="space-y-4">
            <div className="p-4 bg-secondary/30 rounded-lg">
              <h4 className="font-semibold mb-2">Lungs â†” Kidneys (Pulmonary-Renal Syndrome)</h4>
              <p className="text-sm text-muted-foreground">
                <strong>ARDS â†’ AKI:</strong> Hypoxemia from lung failure decreases renal perfusion, triggering prerenal AKI.
                High PEEP can â†“ venous return â†’ â†“ cardiac output â†’ worsening renal hypoperfusion.
                <br /><strong>AKI â†’ ARDS:</strong> Fluid overload from renal failure worsens pulmonary edema and compliance.
                Uremic toxins impair alveolar-capillary barrier integrity.
              </p>
            </div>
            <div className="p-4 bg-secondary/30 rounded-lg">
              <h4 className="font-semibold mb-2">Heart â†” Kidneys (Cardiorenal Syndrome)</h4>
              <p className="text-sm text-muted-foreground">
                <strong>Type 1 (Acute):</strong> Low cardiac output from acute MI/decompensated HF causes prerenal AKI.
                Venous congestion (â†‘ CVP) may be MORE important than low CO in causing AKI.
                <br /><strong>Type 2 (Chronic):</strong> Chronic HF â†’ chronic kidney disease via sustained hypoperfusion and RAAS activation.
                Diuretic resistance develops as GFR â†“.
              </p>
            </div>
            <div className="p-4 bg-secondary/30 rounded-lg">
              <h4 className="font-semibold mb-2">Coagulation â†” All Organs (DIC)</h4>
              <p className="text-sm text-muted-foreground">
                <strong>Mechanism:</strong> Microthrombi from DIC impair microcirculation in EVERY organ (brain, kidneys, lungs, liver, skin).
                Creates a vicious cycle: Organ ischemia â†’ more tissue factor release â†’ worsening DIC.
                <br /><strong>Clinical:</strong> Acral cyanosis (fingers, toes, nose), purpura fulminans (skin necrosis), renal cortical necrosis, stroke, ARDS.
                Mortality 30-80% depending on underlying cause.
              </p>
            </div>
          </div>
        </CardContent>
      </Card>
    </div>
  );
}
